[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].
作者信息
de Alarcón Jiménez R M, Roca Meroño S, Alvarez Fernández G M, García Hernández M A, Navarro Parreño M J, Jimeno Griñó C, Zarco Pedrinaci E, Molina Núñez M
出版信息
Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.
Abstract
摘要
相似文献
1
[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].
Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.
2
DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.
Eur J Haematol. 2010 Mar;84(3):276-7. doi: 10.1111/j.1600-0609.2009.01372.x. Epub 2009 Nov 5.
3
Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.
Leuk Res. 2010 Jul;34(7):e178-80. doi: 10.1016/j.leukres.2010.01.002. Epub 2010 Jan 15.
4
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29.
5
[Hematopoietic stem cell transplantation for multiple myeloma].
Rinsho Ketsueki. 2009 Oct;50(10):1420-6.
6
[Improved prognosis in light chain nephropathy due to multiple myeloma].
Ugeskr Laeger. 2012 Apr 23;174(17):1159-60.
7
Achieving an early myeloma response in patients with kidney impairment.
Adv Chronic Kidney Dis. 2012 Sep;19(5):303-11. doi: 10.1053/j.ackd.2012.07.005.
8
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Clin Cancer Res. 2010 Oct 15;16(20):5079-86. doi: 10.1158/1078-0432.CCR-10-1662. Epub 2010 Aug 25.
9
Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
JNMA J Nepal Med Assoc. 2012 Oct-Dec;52(188):192-5.
10
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
J Clin Oncol. 2010 Feb 10;28(5):800-7. doi: 10.1200/JCO.2009.22.7561. Epub 2010 Jan 4.
Zotero 插件